Table 3.
Medication class in relation to number of falls
| Medication | N of residents taking each med. N = 395 |
0 (N = 171) | 1 (N = 106) | 2-4 (N = 79) | 5+ (N = 34) | P-value |
|---|---|---|---|---|---|---|
| Typical antipsychotics | 30 | 9 (30%) | 9 (30%) | 8 (27%) | 4 (13.3%) | 0.4 |
| Atypical antipsychotics | 156 | 66 (42.3%) | 41 (26.3%) | 33 (21.2%) | 14 (9.0%) | 0.96 |
| SSRI/SNRI | 219 | 97 (44.3%) | 47 (21.5%) | 51 (23.3%) | 22 (10.0%) | 0.03 |
| Diuretic | 193 | 85 (44.0%) | 52 (26.9%) | 36 (18.7%) | 16 (8.3%) | 0.94 |
| Beta blocker | 186 | 82 (44.1%) | 48 (25.8%) | 36 (19.4%) | 17 (9.1%) | 0.95 |
| CCB | 104 | 41 (39.4%) | 29 (27.9%) | 23 (22.2%) | 8 (7.7%) | 0.81 |
| ARB | 54 | 27 (50%) | 11 (20.3%) | 12 (20.45) | 2 (3.7%) | 0.31 |
| Opioid | 211 | 92 (43.65) | 61 (28.9%) | 41 (19.4%) | 17 (8.1%) | 0.83 |
| Statin | 149 | 68 (45.6%) | 39 (26.2%) | 30 (20.1%) | 10 (6.7%) | 0.72 |
| Diabetic | 106 | 45 (42.5%) | 33 (31.1%) | 20 (18.95) | 7 (6.6%) | 0.62 |
| Bisphosphonate | 64 | 28 (43.8%) | 13 (20.3%) | 17 (26.6%) | 6 (9.4%) | 0.41 |
| Benzodiazepines | 164 | 74 (45.1%) | 53 (32.3%) | 26 (15.9%) | 10 (6.1%) | 0.05 |
CCB Calcium Chanel Blocker, ARB Angiotensin Receptor Blocker, SSRI/SNRI Selective Serotonin Reuptake Inhibitors or Selective Serotonin-Norepinepherine Reuptake Inhibitors